Various lysates were subjected to SDS PAGE followed by western blot with 10427-2-AP (Calnexin antibody) at dilution of 1:100000 incubated at room temperature for 1.5 hours.

Immunofluorescent analysis of (10% Formaldehyde) fixed HepG2 cells using Calnexin antibody (10427-2-AP) at dilution of 1:200 and CoraLite®488-Conjugated AffiniPure Goat Anti-Rabbit IgG(H+L). The cytoskeleton was stained with CL594-Phalloidin (red).

Immunohistochemical analysis of paraffin-embedded human breast cancer tissue slide using 10427-2-AP (Calnexin antibody) at dilution of 1:200 (under 10x lens. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

Immunohistochemical analysis of paraffin-embedded human breast cancer tissue slide using 10427-2-AP (Calnexin antibody) at dilution of 1:200 (under 10x lens. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

1X10^6 HeLa cells were stained with 0.2ug Calnexin antibody (10427-2-AP, red) and control antibody (blue). Fixed with 90% MeOH blocked with 3% BSA (30 min). Alexa Fluor 488-conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) with dilution 1:1000.

Immunofluorescent analysis of (4% PFA) fixed HeLa cells using 66903-1-Ig (Calnexin antibody), at dilution of 1:400 and CoraLite®488-Conjugated AffiniPure Goat Anti-Mouse IgG(H+L). Red: staning with CoraLite555-Phalloidin.

Various lysates were subjected to SDS PAGE followed by western blot with 66903-1-Ig (Calnexin antibody) at dilution of 1:20000 incubated at room temperature for 1.5 hours.

Immunofluorescent analysis of (4% PFA) fixed HepG2 cells using CoraLite®594 Calnexin antibody (CL594-10427) at dilution of 1:400.

1X10^6 HeLa cells were intracellularly stained with 0.4 ug CoraLite®594 Anti-Human Calnexin (CL594-10427) (red), or 0.4 ug Control Antibody. Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).

Calnexin fusion protein Ag25535 SDS-PAGE

Immunofluorescent analysis of (4% PFA) fixed HepG2 cells using CL488-66903 (Calnexin antibody) at dilution of 1:100.

Immunofluorescent analysis of (4% PFA) fixed HepG2 cells using CoraLite®488 Calnexin antibody (CL488-10427) at dilution of 1:100.

1X10^6 HeLa cells were intracellularly stained with 0.4 ug CoraLite®488 Anti-Human Calnexin (CL488-10427) (red), or 0.4 ug Control Antibody. Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).

Various lysates were subjected to SDS PAGE followed by western blot with CL594-66903 (Calnexin antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

Immunofluorescent analysis of (4% PFA) fixed SKOV-3 cells using CoraLite®594 Calnexin antibody (CL594-66903, Clone: 2A2C6 ) at dilution of 1:200.

Immunofluorescent analysis of (4% PFA) fixed HepG2 cells using CoraLite®594 Calnexin antibody (CL594-66903, Clone: 2A2C6 ) at dilution of 1:200.

1X10^6 HeLa cells were intracellularly stained with 0.2 ug CoraLite®650 Anti-Human Calnexin (CL650-10427) (red), or 0.2 ug Control Antibody (blue). Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).